PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 21, 2026Journal of Medicinal Chemistry0 citationsOpen Access

Self-Dimerization Induced Proximity Targeting Chimeras (SDIPTAC) Lead to DCAF1 Loss of Function and Inhibition of HIV Replication

View Full Paper
MMMark MabangloSSSmriti SrivastavaYMYusuke Matsui

Key Points

  • The study aims to explore the effects of self-dimerization of DCAF1 on HIV replication and its potential as a therapeutic strategy.
  • Developed seven SDIPTAC compounds for DCAF1 self-dimerization.
  • Analyzed biophysics and crystal structures of DCAF1-SDIPTAC-DCAF1 complexes.
  • Tested efficacy of compounds C8 and C9 in inhibiting HIV replication in CD4+ T cells.
  • Compounds C8 and C9 significantly inhibited Vpr-dependent HIV replication in CD4+ T cells.
  • Biophysical data showed enhanced DCAF1-DCAF1 complex stability and conformation with SDIPTACs.
  • This approach could lead to new therapeutic strategies against HIV and related diseases.

Abstract

DCAF1 is a donut shaped WD40 repeat protein and a substrate receptor of two distinct E3 ligases. In HIV-1 infection, the viral protein Vpr binds to the top surface of DCAF1, changes its substrate specificity to degrade human proteins involved in antiviral activities, enabling HIV-1 to replicate. We hypothesized that artificial top-to-top self-dimerization of DCAF1 could result in DCAF1 loss-of-function and blocking of the Vpr-DCAF1 interaction. We designed and synthesized seven compounds we call SDIPTACs (Self-dimerization Induced Proximity Targeting Chimeras) which artificially induce DCAF1 self-dimerization through the Vpr interaction surface. Interestingly, SDIPTACs C8 and C9, inhibited Vpr-dependent HIV replication in CD4+ T cells. Biophysical data and crystal structures of four DCAF1-SDIPTAC-DCAF1 ternary complexes revealed more details on DCAF1-DCAF1 complex stability, conformation, and their contribution to compound efficacy. Using SDIPTACs with unique mechanism may therefore be an efficient strategy in the development of future therapeutics for HIV infection and other diseases.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mabanglo et al. (2026) studied this question.

synapsesocial.com/papers/6a0ea0f7be05d6e3efb5f5a9https://doi.org/10.1021/acs.jmedchem.6c00126
Ask AI
Helpful
Bookmark
Share
View Full Paper